Corline Biomedical AB (CLBIO) — Free Cash Flow Generation Index

Latest as of March 2024: 0.20x

Corline Biomedical AB (CLBIO) has a Free Cash Flow Generation Index of 0.20x as of March 2024. Free cash flow of Skr461.00K represents 0% of operating cash flow (Skr2.30 Million). Read Corline Biomedical AB (CLBIO) financial obligations for a breakdown of total debt and financial obligations.

FCF Generation Index

0.20x
Free Cash Flow / Operating CF

Free Cash Flow

Skr461.00K
SEK

Operating Cash Flow

Skr2.30 Million
SEK

Capital Expenditures

Skr1.83 Million
SEK

Corline Biomedical AB Free Cash Flow Generation Index (2023–2023)

Historical FCF Generation Index trend for Corline Biomedical AB across 1 annual periods. Explore capital reinvestment ratio of Corline Biomedical AB to see what proportion of operating cash flow is directed to capital expenditures.

Annual Free Cash Flow Generation for Corline Biomedical AB (2023–2023)

Year-by-year Free Cash Flow Generation Index for Corline Biomedical AB. For the full company profile including market capitalisation, see Corline Biomedical AB market capitalisation.

Year FCG Index Free Cash Flow (SEK) Operating CF Capital Expenditures YoY Change
2023 -10.99x Skr-9.73 Million Skr886.00K Skr10.62 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).